• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在台式生物反应器中通过重组大肠杆菌高效生产模仿葡萄球菌溶葡萄球菌素。

Efficient production of Staphylococcus simulans lysostaphin in a benchtop bioreactor by recombinant Escherichia coli.

机构信息

a Department of Pharmaceutical Technology and Biochemistry , Gdansk University of Technology , Gdansk , Poland.

出版信息

Prep Biochem Biotechnol. 2014;44(4):370-81. doi: 10.1080/10826068.2013.829499.

DOI:10.1080/10826068.2013.829499
PMID:24320237
Abstract

Lysostaphin is an enzyme with bactericidal activity against Staphylococcus aureus and other staphylococcal species. In spite of many advantages and promising results of preliminary research, the enzyme is still not widely used in medicine, veterinary medicine, or as a food preservative. One of the most important factors limiting application of the enzyme in clinical or technological practice is the high cost of its production. In this study we have determined the optimal conditions for lysostaphin production in a 5-L batch bioreactor. The enzyme production was based on a heterologous, Escherichia coli expression system designated as pBAD2Lys and constructed earlier in our laboratory. An evident influence of physicochemical conditions of the process (areation, pH and temperature) and composition of the growing media on the amount and activity of produced enzyme was noticed. Efficiency of production of about 13,000 U/L has been achieved in the optimal conditions of the production process: low aeration (400 rpm of mechanical stirrer), pH 6, and temperature 37°C in classical LB medium. Further, about twofold improvement in the production efficiency of the enzyme was achieved as a result of modification of composition of growing media. Finally, more than 80,000 units of lysostaphin were obtained from one (batch) bioreactor with 3 L of culture of E. coli TOP10F' transformed with pBAD2Lys plasmid. To the best of our knowledge, this is the most efficient method of production of recombinant lysostaphin in E. coli expression systems described to date.

摘要

溶葡萄球菌酶是一种对金黄色葡萄球菌和其他葡萄球菌具有杀菌活性的酶。尽管该酶具有许多优点,并在初步研究中取得了有希望的结果,但仍未广泛应用于医学、兽医或食品防腐剂。限制该酶在临床或技术实践中应用的最重要因素之一是其生产成本高。在这项研究中,我们确定了在 5-L 分批生物反应器中生产溶葡萄球菌酶的最佳条件。该酶的生产基于我们实验室早期构建的异源大肠杆菌表达系统 pBAD2Lys。我们注意到,过程的物理化学条件(通气、pH 和温度)和生长培养基的组成对产生的酶的数量和活性有明显影响。在生产过程的最佳条件下,即在低通气(机械搅拌器转速为 400 rpm)、pH6 和 37°C 的经典 LB 培养基中,生产效率达到约 13000 U/L。进一步通过对生长培养基组成的修饰,使酶的生产效率提高了约两倍。最后,从装有 pBAD2Lys 质粒的转化大肠杆菌 TOP10F'的 3 L 培养物的一个(分批)生物反应器中获得了超过 80000 单位的溶葡萄球菌酶。据我们所知,这是迄今为止在大肠杆菌表达系统中描述的生产重组溶葡萄球菌酶最有效的方法。

相似文献

1
Efficient production of Staphylococcus simulans lysostaphin in a benchtop bioreactor by recombinant Escherichia coli.在台式生物反应器中通过重组大肠杆菌高效生产模仿葡萄球菌溶葡萄球菌素。
Prep Biochem Biotechnol. 2014;44(4):370-81. doi: 10.1080/10826068.2013.829499.
2
High-yield production of active recombinant S. simulans lysostaphin expressed in E. coli in a laboratory bioreactor.在实验室生物反应器中,高产表达活性重组 S. simulans 溶葡萄球菌酶的大肠杆菌。
Protein Expr Purif. 2021 Jan;177:105753. doi: 10.1016/j.pep.2020.105753. Epub 2020 Sep 17.
3
Staphylococcus simulans Recombinant Lysostaphin: Production, Purification, and Determination of Antistaphylococcal Activity.模仿葡萄球菌重组溶葡萄球菌酶:生产、纯化及抗葡萄球菌活性的测定
Biochemistry (Mosc). 2016 May;81(5):502-10. doi: 10.1134/S0006297916050072.
4
Cytoplasmic expression of mature glycylglycine endopeptidase lysostaphin with an amino terminal hexa-histidine in a soluble and catalytically active form in Escherichia coli.在大肠杆菌中以可溶且具有催化活性的形式表达带有氨基末端六组氨酸标签的成熟甘氨酰甘氨酸内肽酶溶葡萄球菌素的细胞质表达。
Protein Expr Purif. 2006 Jan;45(1):206-15. doi: 10.1016/j.pep.2005.07.025. Epub 2005 Aug 19.
5
Enhanced production of recombinant lysostaphin using medium engineering.利用培养基工程提高重组溶葡萄球菌酶的产量。
Prep Biochem Biotechnol. 2019;49(5):521-528. doi: 10.1080/10826068.2019.1599393. Epub 2019 Apr 24.
6
The phage K lytic enzyme LysK and lysostaphin act synergistically to kill MRSA.噬菌体K裂解酶LysK与溶葡萄球菌酶协同作用以杀死耐甲氧西林金黄色葡萄球菌(MRSA)。
FEMS Microbiol Lett. 2008 Oct;287(2):185-91. doi: 10.1111/j.1574-6968.2008.01308.x. Epub 2008 Aug 21.
7
Fate of lysostaphin in milk from individual cows through pasteurization and cheesemaking.溶葡萄球菌素在个体奶牛乳汁中经巴氏杀菌和奶酪制作后的去向
J Dairy Sci. 2009 Feb;92(2):444-57. doi: 10.3168/jds.2008-1019.
8
New effective sources of the Staphylococcus simulans lysostaphin.模仿葡萄球菌溶葡萄球菌酶的新有效来源。
J Biotechnol. 2005 May 4;117(2):203-13. doi: 10.1016/j.jbiotec.2005.01.012.
9
Lysostaphin: use of a recombinant bactericidal enzyme as a mastitis therapeutic.溶葡萄球菌酶:一种重组杀菌酶作为乳腺炎治疗剂的应用。
J Dairy Sci. 1991 Dec;74(12):4175-82. doi: 10.3168/jds.S0022-0302(91)78612-8.
10
Cloning, expression, and purification of the Staphylococcus simulans lysostaphin using the intein-chitin-binding domain (CBD) system.使用内含肽-几丁质结合结构域(CBD)系统克隆、表达和纯化模仿葡萄球菌溶葡萄球菌素
Protein Expr Purif. 2001 Aug;22(3):467-71. doi: 10.1006/prep.2001.1454.

引用本文的文献

1
Microbial enzymes as powerful natural anti-biofilm candidates.微生物酶作为强大的天然抗生物膜候选物。
Microb Cell Fact. 2024 Dec 23;23(1):343. doi: 10.1186/s12934-024-02610-y.
2
Biomaterial-based delivery of antimicrobial therapies for the treatment of bacterial infections.基于生物材料的抗菌疗法递送用于治疗细菌感染。
Nat Rev Mater. 2022 Jan;7(1):39-54. doi: 10.1038/s41578-021-00362-4. Epub 2021 Sep 15.
3
Cloning and expression of s lysostaphin enzyme gene in WB600.溶葡萄球菌酶基因在WB600中的克隆与表达
AIMS Microbiol. 2021 Jul 23;7(3):271-283. doi: 10.3934/microbiol.2021017. eCollection 2021.
4
A Rapid Lysostaphin Production Approach and a Convenient Novel Lysostaphin Loaded Nano-emulgel; As a Sustainable Low-Cost Methicillin-Resistant Combating Platform.一种快速溶葡萄球菌素生产方法和一种方便的新型溶葡萄球菌素负载纳米乳凝胶;作为一种可持续的低成本耐甲氧西林金黄色葡萄球菌的防治平台。
Biomolecules. 2020 Mar 12;10(3):435. doi: 10.3390/biom10030435.
5
Production of Lysostaphin by Nonproprietary Method Utilizing a Promoter from Toxin-Antitoxin System.利用毒素-抗毒素系统启动子的非专利方法生产溶葡萄球菌酶。
Mol Biotechnol. 2019 Oct;61(10):774-782. doi: 10.1007/s12033-019-00203-4.